FDA Approves Eisai's Halaven? (Eribulin Mesylate) Injection For Treatment Of Metastat
 

Eisai Inc. announced today that the United States Food and Drug Administration (FDA) has approved Halaven? (eribulin mesylate) Injection for the treatment of patients with metastatic breast cancer who have previously received at least two chemotherapeutic regimens for the treatment of metastatic disease...

More...

Re: FDA Approves Eisai's Halaven? (Eribulin Mesylate) Injection For Treatment Of Meta
 

Does anyone know or have experience with this chemo? I am set to start this on 12-9-10. Just came off of 2 years of tykerb and exloda. Wondering what to expect.

Re: FDA Approves Eisai's Halaven? (Eribulin Mesylate) Injection For Treatment Of Meta
 

I hope Halaven works really well for you, Tonya. I'm hoping for my sake that it becomes available soon in Australia. All the best,
Trish

Re: FDA Approves Eisai's Halaven? (Eribulin Mesylate) Injection For Treatment Of Meta
 

I hope this drug works wonders and you will have it soon also. Do you know if their is hair loss with it? Everything I have found on it seems sort of sketchy even my onc doesnt know much...(not unusual). I have mets to my liver 4 years ago and now possibly something up with ovary. It the first progression in two years. Its just plain scary, but I am keeping my chin up and my fingers crossed. Tonya